Head-line is - Ellex iTrackTM global sales were US$6.1 million for the nine month period, up 40% on prior comparative period.
If you break it down further, sales in both the US and Asia (mainly China) were above 50% with strong momentum. Bodes well for the future.
Re the US, this was despite sales from the Soutwest falling which they are seeking to rectify. East coast sales strong off a low base. Also suggesting increasing traction among surgeons.
Note expecting recent investment in sales/marketing head-count to drive continued momentum in Q4.
ROW is ok - but given this is a US first & then Asia story for iTrack I am pleased with the momentum & provides early validation for the investment in sales / mkt opex (for which ELX was punished by the market in the last reporting season).
- Forums
- ASX - By Stock
- Ann: Glaucoma Business FY18Q3 Sales Update
Head-line is - Ellex iTrackTM global sales were US$6.1 million...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $51.48M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 21.8¢ | $137.7K | 624.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 27766 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 34529 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 27766 | 0.220 |
7 | 251326 | 0.215 |
6 | 143575 | 0.210 |
4 | 132040 | 0.205 |
13 | 136620 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 34529 | 2 |
0.230 | 161803 | 3 |
0.240 | 28253 | 1 |
0.245 | 11000 | 1 |
0.250 | 99617 | 3 |
Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
Last
22.0¢ |
  |
Change
0.010 ( 2.33 %) |
|||
Open | High | Low | Volume | ||
22.5¢ | 22.5¢ | 21.5¢ | 190801 | ||
Last updated 15.47pm 14/06/2024 ? |
Featured News
EYE (ASX) Chart |